𝔖 Bobbio Scriptorium

✦ LIBER ✦

Exploratory INDs: Can they reduce the cost of pharmaceutical development?

✍ Scribed by Lewis B. Kinter; E. Kinter; J. Bridges

Book ID: 113941533
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 56 KB
Volume: 58
Category: Article
ISSN: 1056-8719
DOI: 10.1016/j.vascn.2008.05.123

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The costs of trauma caused by seizures:

The costs of trauma caused by seizures: can they be reduced?

✍ D.L.W Davidson; S Macdonald 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 32 KB

A perspective on risks that impede devel

A perspective on risks that impede development of drugs to modify the course of Alzheimer’s disease: Can they be reduced?

✍ Richard C. Mohs 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 83 KB

How Much Would You Pay for a Ton of Carb

How Much Would You Pay for a Ton of Carbon? It Depends Getting to Zero: Defining Corporate Carbon Neutrality, edited by B. Burtis and I. Watt A Consumer's Guide to Retail Carbon Offset Providers, edited by Bill Burtis Voluntary Carbon Markets: An International Business Guide to What They Are and How They Work, by Ricardo Bayon, Amanda Hawn, and Katherine Hamilton The Greenhouse Gas Protocol: A Corporate Accounting and Reporting Standard (revised edition), by the World Resources Institute and the World Business Council for Sustainable Development Reducing U.S. Greenhouse Gas Emissions: How Much at What Cost? by Jon Creyts, Anton Derkach, Scott Nyquist, Ken Ostrowski, and Jack Stephenson

✍ Bryan Garcia 📂 Article 📅 2009 🏛 MIT Press 🌐 English ⚖ 103 KB